Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing (PGT) for the next-generation primary prevention of breast and ovarian cancer

被引:0
|
作者
Nahshon, C. [1 ]
Oron, G. [1 ]
Kugelman, N. [1 ]
Younes, G. [1 ]
Lavie, O. [2 ]
机构
[1] Lady Davis Carmel Med Ctr, Obstet & Gynecol Dept, IVF Unit, Haifa, Israel
[2] Lady Davis Carmel Med Ctr, Dept Obstet & Gynecol, Haifa, Israel
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-738
引用
收藏
页数:1
相关论文
共 50 条
  • [1] ATTITUDE OF BRCA1/2 MUTATION CARRIERS TOWARDS FERTILITY PRESERVATION, FAMILY PLANNING AND PREIMPLANTATION GENETIC TESTING (PGT) FOR THE NEXT-GENERATION PRIMARY PREVENTION OF BREAST AND OVARIAN CANCER
    Nahshon, Chen
    Lavie, Ofer
    Lahav-Baratz, Shirly
    Oron, Galia
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A13 - A13
  • [2] Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation
    Nahshon, Chen
    Lavie, Ofer
    Oron, Galia
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2023, 40 (12) : 2835 - 2842
  • [3] Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation
    Chen Nahshon
    Ofer Lavie
    Galia Oron
    Journal of Assisted Reproduction and Genetics, 2023, 40 : 2835 - 2842
  • [4] Hereditary breast and ovarian cancer:: primary and secondary prevention for BRCA1 and BRCA2 mutation carriers
    Llort, Gemma
    Blanco, Merce Peris e Ignacio
    MEDICINA CLINICA, 2007, 128 (12): : 468 - 476
  • [5] Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer
    Nahshon, Chen
    Segev, Yakir
    Schmidt, Meirav
    Ostrovsky, Ludmila
    Oron, Galia
    Lavie, Ofer
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A155 - A155
  • [6] Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer
    Trujillano, Daniel
    Weiss, Maximilian E. R.
    Schneider, Juliane
    Koester, Julia
    Papachristos, Efstathios B.
    Saviouk, Viatcheslav
    Zakharkina, Tetyana
    Nahavandi, Nahid
    Kovacevic, Lejla
    Rolfs, Arndt
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (02): : 162 - 170
  • [7] Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
    Derks-Smeets, Inge A. P.
    Schrijver, Lieske H.
    de Die-Smulders, Christine E. M.
    Tjan-Heijnen, Vivianne C. G.
    van Golde, Ron J. T.
    Smits, Luc J.
    Caanen, Beppy
    van Asperen, Christi J.
    Ausems, Margreet
    Collee, Margriet
    van Engelen, Klaartje
    Kets, C. Marleen
    van der Kolk, Lizet
    Oosterwijk, Jan C.
    van Os, Theo A. M.
    Rookus, Matti A.
    van Leeuwen, Flora E.
    Gomez Garcia, Encarna B.
    BRITISH JOURNAL OF CANCER, 2018, 119 (03) : 357 - 363
  • [8] Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
    Derks-Smeets, I.
    Schrijver, L.
    De Die-Smulders, C.
    Tjan-Heijnen, V.
    Van Golde, R.
    Caanen, B.
    Rookus, M.
    Van Leeuwen, F.
    Gomez-Garcia, E.
    HUMAN REPRODUCTION, 2018, 33 : 81 - 82
  • [9] Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
    Inge A. P. Derks-Smeets
    Lieske H. Schrijver
    Christine E. M. de Die-Smulders
    Vivianne C. G. Tjan-Heijnen
    Ron J. T. van Golde
    Luc J. Smits
    Beppy Caanen
    Christi J. van Asperen
    Margreet Ausems
    Margriet Collée
    Klaartje van Engelen
    C. Marleen Kets
    Lizet van der Kolk
    Jan C. Oosterwijk
    Theo A. M. van Os
    Matti A. Rookus
    Flora E. van Leeuwen
    Encarna B. Gómez García
    British Journal of Cancer, 2018, 119 : 357 - 363
  • [10] Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Peterlongo, Paolo
    Chang-Claude, Jenny
    Moysich, Kirsten B.
    Rudolph, Anja
    Schmutzler, Rita K.
    Simard, Jacques
    Soucy, Penny
    Eeles, Rosalind A.
    Easton, Douglas F.
    Hamann, Ute
    Wilkening, Stefan
    Chen, Bowang
    Rookus, Matti A.
    Schmidt, MarjankaK.
    van der Baan, Frederieke H.
    Spurdle, Amanda B.
    Walker, Logan C.
    Lose, Felicity
    Maia, Ana-Teresa
    Montagna, Marco
    Matricardi, Laura
    Lubinski, Jan
    Jakubowska, Anna
    Garcia, Encarna B. Gomez
    Olopade, Olufunmilayo I.
    Nussbaum, Robert L.
    Nathanson, Katherine L.
    Domchek, Susan M.
    Rebbeck, Timothy R.
    Arun, Banu K.
    Karlan, Beth Y.
    Orsulic, Sandra
    Lester, Jenny
    Chung, Wendy K.
    Miron, Alex
    Southey, Melissa C.
    Goldgar, David E.
    Buys, Saundra S.
    Janavicius, Ramunas
    Dorfling, Cecilia M.
    van Rensburg, Elizabeth J.
    Ding, Yuan Chun
    Neuhausen, Susan L.
    Hansen, Thomas V. O.
    Gerdes, Anne-Marie
    Ejlertsen, Bent
    Jonson, Lars
    Osorio, Ana
    Martinez-Bouzas, Cristina
    Benitez, Javier
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (01) : 308 - 316